tonbo fix permeabilization solution (Cytek Biosciences)
Cytek Biosciences is a verified supplier 
Cytek Biosciences manufactures this product 
95
Structured Review
Cytek Biosciences
tonbo fix permeabilization solution
Tonbo Fix Permeabilization Solution, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fixation+buffer+(fix/Fixation+Buffer/pmc12355481-57-22-22
Average 95 stars, based on 1 article reviews
Tonbo Fix Permeabilization Solution, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fixation+buffer+(fix/Fixation+Buffer/pmc12355481-57-22-22
Average 95 stars, based on 1 article reviews
tonbo fix permeabilization solution - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Incubation:Article Title: Mitochondrial protein OPA1 is required for the expansion of effector CD8 T cells. Article Snippet: Article Mitochondrial protein OPA1 is required for the expansion of effector CD8 T cells Article Title: Mitochondrial protein OPA1 is required for the expansion of effector CD8 T cells Article Snippet: .. After washing, cells were incubated in Article Title: Prenatal opioid exposure and maternal HCV infection impair microglia development and function: A patient-specific in vitro model. Article Snippet: Opioids are a class of pain-relieving drugs known to cross the placental and blood brain barriers, exposing the fetus in utero.. Rates of opioid use disorder amongst pregnant individuals in the United States are on the rise, and intravenous routes of opioid administration are highly associated with hepatitis C (HCV) infection.. Newborns with prenatal opioid exposure (POE) are more likely to be small for gestational age and have increased rates of neurodevelopmental delay. Article Title: Prenatal opioid exposure and maternal HCV infection impair microglia development and function: a patient-specific in vitro model Article Snippet: Thawed UCBMC from newborns of full-term, healthy pregnancies (N=9) or iMGL (N=27, 9 Controls, 9 POE HCV−, and 9 POE HCV+) were thoroughly washed with FACS buffer, and stained with a cocktail of the following surface antibodies at a ratio of 1:20 in 50μl/sample of Brilliant Stain Buffer (BD Biosciences): CD14, HLA-DR, CD16, CX3CR1, CD45, CD11b, P2RY12, TMEM119, TREM2, CD68, CD40, CD163, CD115, and CD86 46 , 47 as well as True-Stain Monocyte Block and Human TruStain FcX TM (Fc Receptor Blocking Solution, BioLegend, 1:20). .. After incubation for 30 minutes at 4°C, UCBMCs or the iMGL cell pellet was washed with FACS buffer, fixed for 2 hours ( FACS:Article Title: Prenatal opioid exposure and maternal HCV infection impair microglia development and function: A patient-specific in vitro model. Article Snippet: Opioids are a class of pain-relieving drugs known to cross the placental and blood brain barriers, exposing the fetus in utero.. Rates of opioid use disorder amongst pregnant individuals in the United States are on the rise, and intravenous routes of opioid administration are highly associated with hepatitis C (HCV) infection.. Newborns with prenatal opioid exposure (POE) are more likely to be small for gestational age and have increased rates of neurodevelopmental delay. Article Title: Prenatal opioid exposure and maternal HCV infection impair microglia development and function: a patient-specific in vitro model Article Snippet: Thawed UCBMC from newborns of full-term, healthy pregnancies (N=9) or iMGL (N=27, 9 Controls, 9 POE HCV−, and 9 POE HCV+) were thoroughly washed with FACS buffer, and stained with a cocktail of the following surface antibodies at a ratio of 1:20 in 50μl/sample of Brilliant Stain Buffer (BD Biosciences): CD14, HLA-DR, CD16, CX3CR1, CD45, CD11b, P2RY12, TMEM119, TREM2, CD68, CD40, CD163, CD115, and CD86 46 , 47 as well as True-Stain Monocyte Block and Human TruStain FcX TM (Fc Receptor Blocking Solution, BioLegend, 1:20). .. After incubation for 30 minutes at 4°C, UCBMCs or the iMGL cell pellet was washed with FACS buffer, fixed for 2 hours ( Staining:Article Title: Prenatal opioid exposure and maternal HCV infection impair microglia development and function: A patient-specific in vitro model. Article Snippet: Opioids are a class of pain-relieving drugs known to cross the placental and blood brain barriers, exposing the fetus in utero.. Rates of opioid use disorder amongst pregnant individuals in the United States are on the rise, and intravenous routes of opioid administration are highly associated with hepatitis C (HCV) infection.. Newborns with prenatal opioid exposure (POE) are more likely to be small for gestational age and have increased rates of neurodevelopmental delay. Article Title: Prenatal opioid exposure and maternal HCV infection impair microglia development and function: a patient-specific in vitro model Article Snippet: Thawed UCBMC from newborns of full-term, healthy pregnancies (N=9) or iMGL (N=27, 9 Controls, 9 POE HCV−, and 9 POE HCV+) were thoroughly washed with FACS buffer, and stained with a cocktail of the following surface antibodies at a ratio of 1:20 in 50μl/sample of Brilliant Stain Buffer (BD Biosciences): CD14, HLA-DR, CD16, CX3CR1, CD45, CD11b, P2RY12, TMEM119, TREM2, CD68, CD40, CD163, CD115, and CD86 46 , 47 as well as True-Stain Monocyte Block and Human TruStain FcX TM (Fc Receptor Blocking Solution, BioLegend, 1:20). .. After incubation for 30 minutes at 4°C, UCBMCs or the iMGL cell pellet was washed with FACS buffer, fixed for 2 hours ( Article Title: Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression Article Snippet: Following red blood cell lysis (BioLegend), viability was determined by staining with Ghost dye (Tonbo Biosciences, Inc.) followed by FcR-blocking (Tonbo Biosciences, Inc.). .. Cells were stained with fluorescently labeled antibodies and fixed in Article Title: Mitochondrial protein OPA1 is required for the expansion of effector CD8 T cells Article Snippet: For viability and surface staining, cells were stained in complete media for 10 min at 37°C with Ghost Dye Red 780 (Tonbo) and surface antibodies (1:300, unless noted otherwise) against CD19 (1D3; BD Biosciences), CD8α (53–6.7; BioLegend), CD44 (1:150, IM7; Tonbo), CD45.1 (A20; BioLegend), CD45.2 (104; BioLegend), KLRG1 (2F1/KLRG1; BioLegend), CD127 (1:150, A7R34; BioLegend), and CD98 (RL388; BioLegend). .. After wash with RPMI, cells were fixed and permeabilized for 30 min at RT in FoxP3/Transcription Factor 1x Article Title: Blocking plasma cell fate enhances antigen-specific presentation by B cells to boost anti-tumor immunity. Article Snippet: After surface staining, cells were fixed by 4% PFA, followed by permeabilization and staining with Perm/ WashTM Buffer (BD Biosciences). .. For intranuclear staining, the Article Title: The gut microbiome enhances breast cancer immunotherapy following bariatric surgery. Article Snippet: In all studies, following red blood cell lysis (BioLegend), viability was determined by staining with Ghost dye (Tonbo Biosciences, Inc.) followed by FcR-blocking (Tonbo Biosciences, Inc.). .. Cells were stained with fluorescently labeled antibodies and fixed in Labeling:Article Title: Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progression Article Snippet: Following red blood cell lysis (BioLegend), viability was determined by staining with Ghost dye (Tonbo Biosciences, Inc.) followed by FcR-blocking (Tonbo Biosciences, Inc.). .. Cells were stained with fluorescently labeled antibodies and fixed in Article Title: The gut microbiome enhances breast cancer immunotherapy following bariatric surgery. Article Snippet: In all studies, following red blood cell lysis (BioLegend), viability was determined by staining with Ghost dye (Tonbo Biosciences, Inc.) followed by FcR-blocking (Tonbo Biosciences, Inc.). .. Cells were stained with fluorescently labeled antibodies and fixed in Flow Cytometry:Article Title: Mitochondrial protein OPA1 is required for the expansion of effector CD8 T cells Article Snippet: For viability and surface staining, cells were stained in complete media for 10 min at 37°C with Ghost Dye Red 780 (Tonbo) and surface antibodies (1:300, unless noted otherwise) against CD19 (1D3; BD Biosciences), CD8α (53–6.7; BioLegend), CD44 (1:150, IM7; Tonbo), CD45.1 (A20; BioLegend), CD45.2 (104; BioLegend), KLRG1 (2F1/KLRG1; BioLegend), CD127 (1:150, A7R34; BioLegend), and CD98 (RL388; BioLegend). .. After wash with RPMI, cells were fixed and permeabilized for 30 min at RT in FoxP3/Transcription Factor 1x |